Uncategorized

: What a COVID-19 vaccine would mean for mortgage rates and the housing market

When the coronavirus pandemic first reached U.S. shores earlier this year, worries abounded about how it would affect the country’s housing market. Starting in March, home sales all but ground to a halt as Americans stayed at home to avoid getting sick. All the while, mortgage rates turned lower — and lower and lower. The… Continue reading : What a COVID-19 vaccine would mean for mortgage rates and the housing market

Uncategorized

: Older people, Black and Latinx Americans say they would be hesitant about getting a coronavirus vaccine

Some 46% of Americans ages 50 to 80 would rather wait for others to get vaccinated first before doing it themselves, according to a recent survey. ROBYN BECK/AFP via Getty Images Progress is being made on a coronavirus vaccine — already two candidates have reported Phase 3 clinical trials that indicate an efficacy rate that… Continue reading : Older people, Black and Latinx Americans say they would be hesitant about getting a coronavirus vaccine

Uncategorized

UK regulator set to approve Covid-19 vaccine next week

The UK is poised to become the first western country to approve a Covid-19 vaccine, with the independent regulator set to grant approval within days. Deliveries of the vaccine developed by BioNTech and Pfizer would begin within hours of the authorisation, according to Whitehall insiders. Individuals with knowledge of the process said the first injections… Continue reading UK regulator set to approve Covid-19 vaccine next week

Uncategorized

How AstraZeneca and Oxford found their vaccine under fire

Europe’s former chief drugs regulator has called for calm in the growing controversy over claims made by AstraZeneca and Oxford university for their Covid-19 vaccine in late-stage trials. The Anglo-Swedish drugs company and Oxford’s Jenner Institute revealed earlier this week that, depending on the dosage, their vaccine was either 62 or 90 per cent effective.… Continue reading How AstraZeneca and Oxford found their vaccine under fire

Uncategorized

How Trump’s vaccine effort produced results at ‘warp speed’

Sitting in the shadow of the brutalist health department building in Washington, with only a leather jacket for protection against an autumnal breeze, Moncef Slaoui cuts a defiant figure. Six months after the former GlaxoSmithKline executive left the private sector to become President Donald Trump’s coronavirus vaccine tsar, Mr Slaoui feels his decision has been… Continue reading How Trump’s vaccine effort produced results at ‘warp speed’

Uncategorized

Letter: To be a peoples’ vaccine, Big Pharma must share IP

Your editorial is correct that we need to move fast to vaccinate the world if we are to put the scourge of Covid-19 behind us and rebuild our shattered economy (“Now we need to vaccinate the world”, FT View, November 21). Yet in listing the obstacles to this happening, you do not mention the fundamental… Continue reading Letter: To be a peoples’ vaccine, Big Pharma must share IP

Business news

Doubts raised over AstraZeneca-Oxford vaccine data

Concern is growing about how the University of Oxford and AstraZeneca have handled the read ahead testing of their coronavirus vaccine, which much of the developing world can rely on to emerge from the pandemic. The results were hailed a success for showing an average efficacy of 70% – a figure achieved by pooling the… Continue reading Doubts raised over AstraZeneca-Oxford vaccine data

Uncategorized

Vaccine hopes set off rush for emerging markets

The coronavirus crisis sparked a record flight out of emerging market assets, with more than $90bn leaving bonds and stocks in March alone, according to the Institute of International Finance. But now the asset class is making a comeback. This month’s breakthroughs in the hunt for an effective Covid-19 vaccine have fed optimism over the… Continue reading Vaccine hopes set off rush for emerging markets

Uncategorized

Letter: Vaccine logistics recall the ‘Little Ships of Dunkirk’

The world has just witnessed a remarkable breakthrough with the development of an mRNA vaccine by Pfizer and BioNTech. We should recognise this as a milestone of human ingenuity (“Inside the hunt for a Covid-19 vaccine: how BioNTech made the breakthrough”, the Big Read, November 14). However, Paul Hudson observes (“Beating Covid will take far… Continue reading Letter: Vaccine logistics recall the ‘Little Ships of Dunkirk’

Uncategorized

Vaccine cements Oxford’s place as leader in battle against Covid

Oxford university has emerged as a global leader in the scientific battle against coronavirus — a bright spot in the UK’s generally less than stellar record in handling the pandemic. The university was in the spotlight on Monday for the vaccine that reported encouraging efficacy results, but it also runs the world’s biggest clinical trial… Continue reading Vaccine cements Oxford’s place as leader in battle against Covid